Review clinical trials related to Polyhydramnios. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
The aim of this work is to review the indications, procedural complications and outcomes of amnioreduction in pregnancies complicated by polyhydramnios.
Pregnant women 20- 38 weeks [+1]
Lethal fetal anomalies [+3]
The present trial intends to assess the diagnostic accuracy of symphysis fundal height (SFH) as opposed to SFH combined with point of care ultrasound to measure the fetal abdominal circumference (POC-US-AC) in identifying small and large for gestational age infants (SGA and LGA infants) among low-risk pregnant women cared for by midwives after 35 weeks' gestation. Low risk pregnancies will be evaluated at 35-38, 40, 41, and 41+ weeks' gestation by midwives trained in SFH measurement and POC-US. Formal obstetric US performed by a perinatologist (i.e high risk obstetrician) will be performed in case SFH and/or POC-US suspect fetal growth or amniotic fluid abnormalities. Prenatal evaluations will be compared to actual birthweights.
Maternal age ≥ 18 years and ability to give informed consent. [+5]
Fetal chromosomal or genetic abnormalities if invasive prenatal diagnosis is per... [+23]